PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Phase 3 Clinical Trial Update, page-33

  1. 1,705 Posts.
    lightbulb Created with Sketch. 1856
    https://hotcopper.com.au/data/attachments/5403/5403720-b0bc152c1c1a1384995b6af9f3d86f2d.jpg

    That someone was probably me. Since this email, however, there was a company presentation where Paul was pretty insistent that the 1.5mg/kg twice weekly would produce the same results - so I reckon they are leaning strongly to that dosage. I can understand why the FDA wants to find the lowest effective dosage, and why the company wants to please the FDA by going with this. My preference would be the 2mg because we know full well that it works, but happy to leave to the experts. If 1.5mg/kg works just as well, then we get the added benefit of knocking 25% off procurement costs of the API from Bene for a course of treatment too.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.